Motiva breast implants exhibit an exceptionally low rate of capsular contracture (0.5%) due to their "Silk" surface, which is thought to limit bacterial adhesion and inflammation.

noli's read

Dr. Youn highlights a specific advantage related to the surface technology of Motiva implants, a major concern in cosmetic surgery. The 5-year clinical data cited correspond to studies published by the manufacturer (prospective observational studies), which indeed report very low complication rates compared to historical averages observed with differently textured implants. The hypothesis regarding the "Silk" (nanotextured) surface is supported by laboratory research suggesting that lower roughness limits the formation of bacterial biofilms, a factor known to trigger the immune response leading to contracture. However, it is important to note that these results come from industry-funded studies, which necessitates cautious interpretation. The link between this reduction in inflammation and the prevention of "breast implant illness" remains, as the creator acknowledges, speculative and without solid clinical evidence to date. In summary, the reduction in the risk of capsular contracture is a documented advancement, but its impact on other systemic symptoms remains an area of scientific uncertainty.

the sources

No named source held this one up — that absence is part of the verdict.